Breztri Aerosphere

Breztri Aerosphere (budesonide/glycopyrrolate/formoterol) is a prescription medication used to treat COPD. A twice-daily triple-therapy inhaler for the maintenance treatment of chronic obstructive pulmonary disease.

Combines an inhaled steroid with two bronchodilators to reduce inflammation and relax airway muscles.

Commonly reported side effects of Breztri Aerosphere include Respiratory infections, Thrush, Cough, Headache, and Urinary tract infection. This is not a complete list — tell your doctor or pharmacist about any side effects you experience.

Breztri Aerosphere does not carry an FDA Boxed Warning, but every prescription medicine has risks and possible interactions. Always follow your doctor's instructions and read the medication guide that comes with it.

The active ingredient in Breztri Aerosphere is budesonide/glycopyrrolate/formoterol, which belongs to a class of medicines known as Inhaled Corticosteroid + LAMA + LABA.

Breztri Aerosphere is manufactured by AstraZeneca. It was first approved in 2020.

You may be able to lower the cost of Breztri Aerosphere by using a free pharmacy discount card or by comparing prices across pharmacies before you fill your prescription. Savings vary by pharmacy and location.